Lu Xingyu's one-to-one status quo is survival. Shanghai Aibien Gene Technology Co., Ltd. was founded on the detection technology of gene epigenetics in Professor He Chuan's laboratory of the University of Chicago, USA, focusing on the research and development, production and service of molecular drug diagnosis (gene diagnosis) products, with a research and development team composed of senior technicians in medicine and molecular drug biology and strong intellectual property rights.